Tonix Pharmaceuticals Reports Positive Immune Response Results from COVID-19 Vaccine Candidate TNX-1800, Following Vaccination of Non-Human Primates

NEXT STORY
Fennec Pharmaceuticals Announces Third Quarter 2020 Financial Results and Provides Business Update
PREV STORY
MATEON PROVIDES CORPORATE UPDATE AND ANNOUNCES THIRD QUARTER 2020 FINANCIAL RESULTS
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Roche reports very strong performance in the first half of 2019 – Outlook raised

author_avatar
NASDAQ Market News

Global TNF Alpha Inhibitors Market Report 2020: Market is Expected to Recover and Reach $42.86 Billion in 2023 – Long-term Forecast to 2025 & 2030

author_avatar
NASDAQ Market News

Tiziana Life Sciences plc (“Tiziana” or the “Company”) – Tiziana announces completion of the clinical trial with nasally administered Foralumab, its proprietary fully human anti-CD3 monoclonal antibody, for the treatment of COVID-19 patients in Brazil

author_avatar
NASDAQ Market News